Utility of GnRH-agonists for Fertility Preservation in Women With Operable Breast Cancer: Is It Protective? - Wikidata - wikimedia - TriplyDB

Utility of GnRH-agonists for Fertility Preservation in Women With Operable Breast Cancer: Is It Protective?

Utility of GnRH-agonists for Fertility Preservation in Women With Operable Breast Cancer: Is It Protective?

http://www.wikidata.org/entity/Q37679148

about

Preserving fertility in patients undergoing treatment for breast cancer: current perspectives.Dexrazoxane abrogates acute doxorubicin toxicity in marmoset ovary Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.Fertility Rates in Young Korean Breast Cancer Patients Treated with Gonadotropin-Releasing Hormone and Chemotherapy Sexual and fertility adverse effects associated with chemotherapy treatment in women.Premature ovarian insufficiency: from pathogenesis to clinical management.News on the medical treatment of young women with early-stage HER2-negative breast cancer.

P2860

Q33939688-087B64F4-8D0E-4415-88AE-7D685CC1773E Q35201332-7A9446C1-6DAE-4A6D-AA79-0E5A00D789B0 Q35766397-FF74432F-3460-48A8-9991-8130F6BE971C Q37735971-5A2D1EF8-F1FE-4E6D-8FCD-D6E7A74539E6 Q38208378-49A7B25F-B886-4B6A-871F-A3478F0BF496 Q38321876-05A2476F-03E3-4835-98DC-FFC1AAC79A6C Q38870541-93850E47-9855-4845-BACC-074DBD2F99E9

P2860

Utility of GnRH-agonists for Fertility Preservation in Women With Operable Breast Cancer: Is It Protective?

http://www.wikidata.org/entity/Q37679148

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Utility of GnRH-agonists for F ...... east Cancer: Is It Protective?

@en

Utility of GnRH-agonists for F ...... east Cancer: Is It Protective?

@nl

type

label

Utility of GnRH-agonists for F ...... east Cancer: Is It Protective?

@en

Utility of GnRH-agonists for F ...... east Cancer: Is It Protective?

@nl

prefLabel

Utility of GnRH-agonists for F ...... east Cancer: Is It Protective?

@en

Utility of GnRH-agonists for F ...... east Cancer: Is It Protective?

@nl

P1433

Q37679148-7EFC5A14-9CE1-494B-9CE2-7B778F9EC945

P1476

Q37679148-CE793E11-BAAC-4984-86F9-DD8EFCC6ECEC

P2093

Q37679148-1BDB13BC-22CE-425C-95E6-CFEAC4AAE1CE

Q37679148-B57060D3-A677-4540-960A-429DC35C68B3

P2860

Q37679148-10B24409-A1F9-4445-9D8F-AC1DF824FC2C

Q37679148-1395F7D1-74A8-4DA9-96DE-6F6C64199CF9

Q37679148-1484F95A-CBD7-463E-817D-52275B46A2E2

Q37679148-161A5EAE-B90C-4290-8AAE-602C45D110B8

Q37679148-163FB289-EFD3-42CD-84ED-90BCAF1B4E36

Q37679148-1C0E6B7D-EF90-4E0E-A3E1-13B1CDF53836

Q37679148-2299FC00-14F8-4CA9-BBD0-7F55AEB218D0

Q37679148-272DDC10-E477-4CF3-86C5-8940C1F6679F

Q37679148-38603CDF-1AC8-4643-9E68-61F9F50E0222

Q37679148-47A4FACE-DD00-44B0-988F-0050E067CD9D

P2888

Q37679148-DBC74CAF-B1D1-4317-B40D-39000648BE77

P304

Q37679148-A2200FDF-577C-4B8C-9243-6EF738512093

P31

Q37679148-835E93DC-2B34-4481-B853-8D68FBA7E61D

P356

Q37679148-65CBEBDE-4E1B-4029-A8C9-A7CA07081A45

P433

Q37679148-4E9AA2B7-934A-4560-BD8B-4AE645B8A78B

P478

Q37679148-D61A2915-1214-4C8A-9032-93BB65FE2222

P50

Q37679148-4F1AE3E8-3A80-4FAB-B0F9-A383983256D2

P577

Q37679148-B8892A4B-6C89-4551-BEEE-AF8E95F68A7E

P698

Q37679148-CAB69C65-8336-43D5-8FF0-6255F3CA57A0

P932

Q37679148-9FE59265-D920-47C9-A638-0C59558F243A

P356

S12609-013-0123-Y

P1433

Current breast cancer reports

P1476

Utility of GnRH-agonists for F ...... east Cancer: Is It Protective?

@en

P2093

Kutluk Oktay

http://www.w3.org/2001/XMLSchema#string

Volkan Turan

http://www.w3.org/2001/XMLSchema#string

P2860

Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer

Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women

Cancer statistics, 2013

Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy

Multi-factorial role of GnRH-I and GnRH-II in the human ovary

Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans

Molecular biology of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and their receptors in humans

Sphingosine-1-phosphate: an enigmatic signalling lipid

Breast cancer before age 40 years.

Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature

P2888

s12609-013-0123-y

P304

302-308

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12609-013-0123-Y

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Giuliano Bedoschi

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24707345

http://www.w3.org/2001/XMLSchema#string

P932

3972621

http://www.w3.org/2001/XMLSchema#string